'Small cell cancer' presentation slideshows

adjuvant therapy in non-small cell lung cancer

adjuvant therapy in non-small cell lung cancer. the Lebanese Society of Medical Oncology commitment to cure cancer november 13-15, 2008 Beirut. Dominique H. Grunenwald, MD Professor in Thoracic and Cardiovascular Surgery Hopital Tenon, University of Paris. France.

1.08k views • 66 slides

[Insert your name and information here]

Tobacco 101. [Insert your name and information here]. 1. Overview. Traditional tobacco Commercial tobacco Smokeless tobacco Tobacco & Cancer Tobacco & Diabetes Tobacco & Secondhand smoke. 2. Traditional Tobacco Stories.

597 views • 43 slides

Chemotherapy in prostate cancer

Chemotherapy in prostate cancer. Dr.Mina Tajvidi Radiation oncologist. Chemotherapy in prostate cancer. Neoadjuvant chemotherapy adjuvant chemotherapy chemotherapy in hormone refractory prostate cancer. Neoadjuvant chemotherapy (Radical prostatectomy).

685 views • 25 slides

Lung Cancer

522 views • 25 slides

Types and Symptoms of Prostate Cancer

Types and Symptoms of Prostate Cancer

166 views • 16 slides

Radon Mitigation Setup Step By Action - Conserve Numerous Dollars

Radon is accountable for at least 15,000 to 20,000 getting lung cancer deaths each year in the U.S. In fact, radon direct exposure is the second-leading reason for lung cancer in the United States. This tragedy is intensified by the truth that both radon screening and radon mitigation are easy and inexpensive. While nationally 1 in 15 homes might reveal harmful levels of radon, the average levels in many parts of the mid-Atlantic may be 2 to 3 times higher than this. There are no immediate signs of radon exposure and you can not see, taste, feel, or smell radon. Cancer can reveal up five to 25 years after direct exposure and about 12% of lung cancer medical diagnoses are triggered by radon.

23 views • 2 slides